The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q2 2021 call → NOWe need to determine if management conveys that the reported results do not represent the business actually running today, i.e., the business is ahead of the reported period. Look for indications that the reported period is stale relative to current operations. Key points from transcript: - Pat mentions "market dynamics remain a challenge" due to COVID, but "optimistic that as the country continues to recover... Firdapse revenue trajectory will ramp further upward in the second half of this year and beyond." This is forward-looking, not necessarily saying current business is ahead. - Jeff: "Q2 new patient enrollments were 111% higher for the quarter versus the same quarter last year." That's growth, but not necessarily a gap. - Jeff: "We continue to see a gradual recovery from the impacts of the COVID-19 pandemic in Q2 when compared to Q1 2021." That's a recovery, but not a statement that the reported period is stale. - Pat mentions hiring new executives, business development activities, but that's about future strategy. - Steve: "We have also completed a number of advisory panel meetings... to establish the optimum target characteristics of the long-acting formulation." That's development, not current business. - Pat: "We are currently evaluating and conducting due diligence on what we believe are several very exciting opportunities to expand our portfolio... hoping to complete one or more company or product acquisitions before the end of this year." That's future plans, not current operations. - No explicit statement that the reported numbers are behind the current business. The tone is typical results call with growth and optimism. The question asks if management conveys that the reported results do not represent the business actually running today. They do not say that. They acknowledge COVID impact but see recovery. They don't say "the numbers are stale" or "we've already moved beyond." They talk about future growth, but that's standard. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.